Skip to main content

Table 1 General characteristic of the study participants at the baseline examination and follow-up by gender*

From: Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study

 

Men (n = 1431)

Women (n = 2036)

General characteristics

At baseline

At follow-up

P value

At baseline

At follow-up

P value

Age (year)

45.7 ± 14.9

48.9 ± 14.8

< 0.001

43.5 ± 13.6

46.8 ± 13.6

< 0.001

Weight (kg)

75.4 ± 12.3

77.6 ± 12.7

< 0.001

68.8 ± 11.8

70.5 ± 12.0

< 0.001

BMI (kg/m2)

26.2 ± 3.8

26.8 ± 3.9

< 0.001

28.1 ± 4.6

29.1 ± 4.8

< 0.001

WC (cm)

89.8 ± 10.8

95.4 ± 10.3

< 0.001

89 ± 12.2

92.8 ± 12.3

< 0.001

FPG (mmol/l)

5.4 ± 1.5

5.6 ± 1.7

< 0.001

5.6 ± 2.1

5.7 ± 2.2

< 0.001

Triglyceride (mmol/l)

2.1 ± 1.4

2 ± 1.3

< 0.001

1.9 ± 1.2

1.8 ± 1.2

< 0.001

HDL-C (mmol/l)

1.0 ± 0.2

0.9 ± 0.2

< 0.001

1.2 ± 0.3

1 ± 0.2

< 0.001

SBP (mmHg)

122.3 ± 19.1

120.2 ± 18.5

< 000.1

119.9 ± 19.4

118.2 ± 20.1

< 0.001

DBP (mmHg)

78.6 ± 11.0

75.7 ± 11.1

< 0.001

78.6 ± 10.3

75.8 ± 10.1

< 0.001

ATPIII MetS, no (%)

394 (27.5)

484 (33.8)

< 0.001

856 (42)

969 (47.6)

< 0.001

Smokers, no (%)

574 (40.4)

628 (44.2)

< 0.001

111 (5.5)

138 (6.8)

< 0.001

Medication for, no (%)

      

   Dyslipidemia

31 (2.2)

43 (3.0)

< 0.001

111 (5.5)

101 (5.0)

< 0.001

   Hypertension

94 (6.6)

95 (6.7)

< 0.001

235 (11.6)

270 (13.3)

< 0.001

   Diabetes

39 (2.7)

68 (4.8)

< 0.001

109 (5.4)

158 (7.8)

< 0.001

  1. * Plus, minus represents mean ± standard deviation
  2. BMI: body mass index, WC: waist circumference, FPG: fasting plasma glucose, SBP: systolic blood pressure, DBP: diastolic blood pressure
  3. Smokers are those with current or past history of smoking.
  4. ATPIII defined Mets: metabolic syndrome by the ATPIII definition which is indicated in reference 18.
Back to article page